Optimal Pacing Rate for Cardiac Resynchronization Therapy

This study is looking at whether a faster heart rate set by a pacemaker can improve how well people with persistent atrial fibrillation (a type of irregular heartbeat) and heart failure can exercise. Specifically, it compares a pacing rate of 80 beats per minute (bpm) to 60 bpm. You might be able to join if you are 18 to 90 years old, have persistent or permanent atrial fibrillation, and had a cardiac resynchronization therapy (CRT) device or conduction system pacing implanted between 3 months and 5 years ago. You also need to have had an intrinsic AVN block (a problem with the heart's electrical system) or AVN ablation (a procedure to treat irregular heartbeats) in the same timeframe, and a left ventricular ejection fraction (LVEF) of 50% or higher. The main goal is to see if the 80 bpm pacing rate improves your exercise tolerance, measured by how far you can walk in six minutes, after 3 months. The current recruitment status is unclear.

Study design
This is a randomized crossover study involving 60 participants. Participants will switch between a pacing rate of 60 bpm and 80 bpm.
What's involved
You would have an electrocardiogram, echocardiogram, pacemaker check, blood tests, and a six-minute walk test at the start, 3 months, and 6 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 6 months, with the primary endpoint measured at 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06445439

Optimal Pacing Rate for Cardiac Resynchronization Therapy

UNKNOWN
NAAges 18–90InterventionalTreatment
Medstar Health Research Institute
~60 participants
Updated 2024-10-15 on ClinicalTrials.gov
What's tested:Pacing rate of 80 bpmPacing rate of 60 bpm

At a glance

Recruiting sites
4 of 5 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Exercise tolerance as measured by the Six-Minute Walk Test
Measured over 3 months
Atrial Fibrillation, Persistent

NCT06445439

Where you'd take part

This study runs at 5 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbiastudy coordinator listed

    Recruiting

  • MedStar Heart and Vascular Office at Fairfax

    Fairfax, Virginiastudy coordinator listed

    Recruiting

  • MedStar Southern Maryland Hospital

    Clinton, Marylandstudy coordinator listed

    Recruiting

  • MedStar Union Memorial Hospital

    Baltimore, Marylandstudy coordinator listed

    Not yet recruiting

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbiastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Athanasios Thomaides, MD · PRINCIPAL_INVESTIGATOR · MedStar Health

Opens a ready-to-send draft in your own email app — review before sending.

  • Exercise tolerance as measured by the Six-Minute Walk Test3 months

    Exercise tolerance as measured by the Six-Minute Walk Test